Gelonghui, April 19, 丨 Haizheng Pharmaceutical (600267.SH) announced that on April 18, 2024, the company's third share repurchase plan was completed. It actually repurchased 11.6872 million shares, accounting for 0.97% of the company's total share capital. The highest repurchase price was 9.75 yuan/share, the lowest repurchase price was 7.17 yuan/share, the average repurchase price was 8.47 yuan/share, and the total capital used was 98.99.27 million yuan (excluding transaction fees).
海正药业(600267.SH)：完成回购 已实际回购0.97%公司股份
Haizheng Pharmaceutical (600267.SH): Completed the repurchase and actually repurchased 0.97% of the company's shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.